Showing results (71-80 of 471) with videos related to
Sort By:
Pageof 48
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 20, 2013
Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infectionBenoit Visseaux, Lucile Larrouy, Ruxandra Calin, et al.Journal of Hepatology|May 1, 2016
Fatty liver is an independent predictor of early carotid atherosclerosisRaluca Pais, Philippe Giral, Jean-François Khan, et al.Atherosclerosis|February 5, 2010
Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stressPhilippe Giral, Vlad Ratziu, Philippe Couvert, et al.Annals of Internal Medicine|June 19, 2002
Truth survival in clinical research: an evidence-based requiem?Thierry Poynard, Mona Munteanu, Vlad Ratziu, et al.Digestive Diseases and Sciences|March 21, 2003
Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet indexRobert P Myers, Mercedes De Torres, Françoise Imbert-Bismut, et al.Journal of Hepatology|June 12, 2013
From NAFLD in clinical practice to answers from guidelinesFabio Nascimbeni, Raluca Pais, Stefano Bellentani, et al.European Journal of Internal Medicine|January 3, 2015
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver diseaseRaluca Pais, Elena Rusu, Diana Zilisteanu, et al.Alimentary Pharmacology & Therapeutics|July 22, 2024
Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre prospective studyPhilippe Sultanik, Guillaume Lherault, Charlotte Bouzbib, et al.Hepatology (Baltimore, Md.)|May 19, 2025
Detecting at-risk steatotic liver disease and liver fibrosis in the communityLeon A Adams, Maja Thiele, Emmanuel A TsochatzisHepatology (Baltimore, Md.)|June 28, 2003
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis CThierry Poynard, Vlad Ratziu, John McHutchison, et al.Pageof 48